Rsv vaccine

Although most people recover completely, some cases can be fatal or have lasting effects.

Dr. Christy explains the data behind the two new RSV vaccines, Abrysvo and Arexvy. There are pros and cons to getting the ...

A new vaccine is out for the Respiratory Syncytial Virus (RSV) for those age 60 and over, called "Arexvy". Many patients have ...

Respiratory syncytial virus (RSV) is most serious for infants and older adults. RSV can make people in these age groups unable to ...

Dr. Kwame Akoto, family physician, Kaiser Permanente, explains that RSV is a common respiratory virus that can be serious for ...

ABC News chief medical correspondent Dr. Jen Ashton talks about promising data that shows an RSV vaccine can be used for ...

After six decades of research, the world's first vaccine to protect against RSV has been green-lit by the FDA. In Health Minute ...

Respiratory syncytial virus, or RSV, strikes fear into the hearts of parents, especially those with very young babies. It's not very kind ...

Epidemiologist Dr. Prabhat Jha says the new RSV vaccine will play an important role as flu season in Canada approaches.

ABC News chief medical correspondent Dr. Jen Ashton explains the decision of a CDC panel of advisors, who voted to ...

RSV can be very dangerous, and it's important to get vaccinated.

Subscribe for the latest science breakdowns! And, become a member to chat 1:1 about science related topics! The first vaccine ...

In 2023, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommended ...

CDC changes its RSV vaccine recommendations.

Two people who received Pfizer's RSV vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome.

A vaccine is being rolled out for RSV - short for respiratory syncytial virus - for the first time among pregnant women and older ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital, talks about Johnson and Johnson's decision stop ...

Researchers will collect data from electronic health records at HealthPartners and a few other healthcare systems nationwide.

According to the CDC, it is estimated that between 60000-160000 older adults in the United States are hospitalized and ...

It's the world's first vaccine for RSV and the Food and Drug Administration gave the nod Wednesday. It's called Arexvy and the ...

Dr. Mike Coates talks about the respiratory infection RSV, what it is, what the common symptoms are and how getting the ...

New vaccines have been licensed in the US to protect adults age 60 years and older from respiratory syncytial virus (RSV).

In May 2023, the Food and Drug Administration (FDA) approved the first vaccines for prevention of RSV-associated lower ...

Did you know that the battle against RSV, a significant yet often overlooked respiratory virus, has recently seen groundbreaking ...

Who should get vaccinated for RSV? What are the side effects and safety concerns for RSV vaccines? Your vaccine questions ...

#ABCNews #pfizer #rsv #vaccine.

Pfizer just released data on a shot for pregnant women to combat the illness hitting children nationwide. Subscribe: ...

The new RSV vaccines are recommended for pregnant women in their third trimester and adults 60 and older Get more ...

It appears like people aged 60 and over will have access to two new RSV vaccines this fall. A CDC advisory board signed off on ...

Pfizer has released new data from its trials for a potential maternal vaccine against the common respiratory virus RSV that shows ...

NBC's medical contributors Dr. Natalie Azar and Dr. John Torres discuss the rising risks of RSV and whooping cough this year, ...

This segment of Dr. Barbara Taylor's discussion on Lungcast featured the topic of current RSV vaccines recommended for adults ...

A recent large-scale study showed that RSV vaccine is 80% effective against RSV-associated hospitalizations and deaths in older ...

Here's what you need to know about the new RSV vaccine as Canadians over 60 received doses this week. Subscribe to CTV ...

CNBC's Angelica Peebles reports on early success on a new vaccine.

The CDC has revised its recommendations for R.S.V. vaccines.

This is the same vaccine that the FDA approved in May for people 60-and-up.

Studies show the new vaccine reduced the risk of getting RSV (Respiratory Syncytial Virus) by nearly 83%. More news: ...

The FDA approved an RSV vaccine this week for pregnant women but some Arizona doctors are urging caution about getting the ...

A first-ever vaccine for respiratory syncytial virus or RSV is approved by the FDA. KPBS Reporter Melissa Mae tells us who will be ...